Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

146 results
  1. Sirolimus is used in combination with other medications to prevent rejection of kidney transplants. Sirolimus is in a class of medications called immunosuppressants. ...
  2. Sirolimus (with albumin) injection is used to treat a certain type of epithelioid cell tumor (soft tissue ... body or can not be removed by surgery. Sirolimus is in a class of medications called kinase ...
  3. ... vincristine and ticlopidine has also been reported.[ 28 ] Sirolimus Secondary to promising case reports, case series, and ... Supportive care and close monitoring of infants on sirolimus A case report described two children with kaposiform ...
  4. ... malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results ... Tai SS, et al. Randomized controlled trial of sirolimus for renal transplant recipients at high risk for ...
  5. ... The targeted therapy drugs thalidomide , sorafenib , pazopanib , and sirolimus are angiogenesis inhibitors used to treat childhood vascular ... to remove the tumor. Laser therapy . Targeted therapy ( sirolimus ). Juvenile Nasopharyngeal Angiofibroma Juvenile nasopharyngeal angiofibromas are benign ...
  6. ... et al. Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: ... Wan Z, Lu WL, Wang JH. Comparison of sirolimus- and paclitaxel-eluting stents in patients undergoing primary ...
  7. ... studied to treat malignant peripheral nerve sheath tumor . Sirolimus and temsirolimus are types of mTOR inhibitor therapy . ... being studied in combination with the mTOR inhibitor sirolimus for malignant peripheral nerve sheath tumors that cannot ...
  8. ... with this combination.Talk with your health provider.Sirolimus (Rapamune)Sirolimus is changed and broken down by the body. ... might decrease how quickly the body breaks down sirolimus. This might increase levels of sirolimus in the ...
  9. ... Banning A, et al. The use of the Sirolimus-eluting CYPHER Select plus coronary stent in patients ... insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the ...
  10. ... sotrastaurin’/exp ‘tofacitinib’/exp alemtuzumab belatacept' everolimus' rapamycin sirolimus sotrastaurin tofacitinib Drug Monitoring timepoints (Cyclosporine) NA (‘area ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last